+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

In-Vitro Diagnostics Market Research Report by Component (Data Management Software, Instruments, and Reagents & Kits), Technology, Application, End User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 240 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 4904897
UP TO OFF until Mar 31st 2023
The Global In-Vitro Diagnostics Market size was estimated at USD 63.34 billion in 2022, USD 67.36 billion in 2023, and is projected to grow at a CAGR of 6.48% to reach USD 104.75 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global In-Vitro Diagnostics Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global In-Vitro Diagnostics Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global In-Vitro Diagnostics Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global In-Vitro Diagnostics Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global In-Vitro Diagnostics Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Component, the market is studied across Data Management Software, Instruments, Reagents & Kits, and Services.
  • Based on Technology, the market is studied across Clinical Chemistry, Coagulation & Hemostasis, Hematology, Immunochemistry, Microbiology, Molecular Diagnostics, and Urinalysis. The Clinical Chemistry is is further studied across Basic Metabolic Panel, Electrolyte Panel, Lipid Profile, Liver Panel, Renal Profile, Specialty Chemical Tests, and Thyroid Function Panel. The Immunochemistry is is further studied across Enzyme-Linked Immunosorbent Assay, Enzyme-Linked Immunospot Assays, Radioimmunoassay, Rapid Test, and Western Blotting. The Enzyme-Linked Immunosorbent Assay is is further studied across Chemiluminescence Immunoassays, Colorimetric Immunoassays, and Fluorescence Immunoassays. The Molecular Diagnostics is is further studied across DNA Sequencing & Next-Generation Sequencing, Hybridization, Isothermal Nucleic Acid Amplification Technology, Microarray, and Polymerase Chain Reaction.
  • Based on Application, the market is studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, HIV/Aids, Infectious Diseases, Nephrology, and Oncology.
  • Based on End User, the market is studied across Hospitals & Care Providers, Laboratories, and Patient Self-Testing.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global In-Vitro Diagnostics Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global In-Vitro Diagnostics Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global In-Vitro Diagnostics Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global In-Vitro Diagnostics Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global In-Vitro Diagnostics Market, including Abbott Laboratories, Agilent Technologies Inc., Arkray Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biomérieux SA, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Grifols SA, Ortho-Clinical Diagnostics, Inc., Qiagen GmbH, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global In-Vitro Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global In-Vitro Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In-Vitro Diagnostics Market?
4. What is the competitive strategic window for opportunities in the Global In-Vitro Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the Global In-Vitro Diagnostics Market?
6. What is the market share of the leading vendors in the Global In-Vitro Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the Global In-Vitro Diagnostics Market?
Frequently Asked Questions about the Global In-Vitro Diagnostics Market

What is the estimated value of the Global In-Vitro Diagnostics Market?

The Global In-Vitro Diagnostics Market was estimated to be valued at $63.34 Billion in 2022.

What is the growth rate of the Global In-Vitro Diagnostics Market?

The growth rate of the Global In-Vitro Diagnostics Market is 6.4%, with an estimated value of $104.75 Billion by 2030.

What is the forecasted size of the Global In-Vitro Diagnostics Market?

The Global In-Vitro Diagnostics Market is estimated to be worth $104.75 Billion by 2030.

Who are the key companies in the Global In-Vitro Diagnostics Market?

Key companies in the Global In-Vitro Diagnostics Market include Abbott Laboratories, Agilent Technologies Inc., Arkray Inc., Becton, Dickinson and Company, Bio, Rad Laboratories Inc., Biomérieux SA, Danaher Corporation and F. Hoffmann.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Geriatric population and prevalence of chronic and infectious diseases in Americas
5.1.1.2. Growing awareness on self-testing and personalized medicine
5.1.1.3. Increasing adoption automated instruments and equipment in laboratories
5.1.2. Restraints
5.1.2.1. Unfavorable reimbursement
5.1.3. Opportunities
5.1.3.1. Development of condition-specific markers and tests
5.1.3.2. Integration of advanced technologies in companion diagnostics
5.1.4. Challenges
5.1.4.1. Changing the regulatory landscape
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. In-Vitro Diagnostics Market, by Component
6.1. Introduction
6.2. Data Management Software
6.3. Instruments
6.4. Reagents & Kits
6.5. Services

7. In-Vitro Diagnostics Market, by Technology
7.1. Introduction
7.2. Clinical Chemistry
7.3.1. Basic Metabolic Panel
7.3.2. Electrolyte Panel
7.3.3. Lipid Profile
7.3.4. Liver Panel
7.3.5. Renal Profile
7.3.6. Specialty Chemical Tests
7.3.7. Thyroid Function Panel
7.3. Coagulation & Hemostasis
7.4. Hematology
7.5. Immunochemistry
7.6.1. Enzyme-Linked Immunosorbent Assay
7.6.2.1. Chemiluminescence Immunoassays
7.6.2.2. Colorimetric Immunoassays
7.6.2.3. Fluorescence Immunoassays
7.6.2. Enzyme-Linked Immunospot Assays
7.6.3. Radioimmunoassay
7.6.4. Rapid Test
7.6.5. Western Blotting
7.6. Microbiology
7.7. Molecular Diagnostics
7.8.1. DNA Sequencing & Next-Generation Sequencing
7.8.2. Hybridization
7.8.3. Isothermal Nucleic Acid Amplification Technology
7.8.4. Microarray
7.8.5. Polymerase Chain Reaction
7.8. Urinalysis

8. In-Vitro Diagnostics Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cardiology
8.4. Diabetes
8.5. Drug Testing
8.6. HIV/Aids
8.7. Infectious Diseases
8.8. Nephrology
8.9. Oncology

9. In-Vitro Diagnostics Market, by End User
9.1. Introduction
9.2. Hospitals & Care Providers
9.3. Laboratories
9.4. Patient Self-Testing

10. Americas In-Vitro Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific In-Vitro Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa In-Vitro Diagnostics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Product Portfolio Analysis, By Key Player
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Agilent Technologies Inc.
14.3. Arkray Inc.
14.4. Becton, Dickinson and Company
14.5. Bio-Rad Laboratories Inc.
14.6. Biomérieux SA
14.7. Danaher Corporation
14.8. DiaSorin S.p.A.
14.9. F. Hoffmann-La Roche Ltd.
14.10. Grifols SA
14.11. Ortho-Clinical Diagnostics, Inc.
14.12. Qiagen GmbH
14.13. Siemens AG
14.14. Sysmex Corporation
14.15. Thermo Fisher Scientific, Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET DYNAMICS
FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COMPONENT, 2030
FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, 2018-2030 (USD BILLION)
FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD BILLION)
FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD BILLION)
FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD BILLION)
FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2030 (USD BILLION)
FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD BILLION)
FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, 2018-2030 (USD BILLION)
FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, 2018-2030 (USD BILLION)
FIGURE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, 2018-2030 (USD BILLION)
FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, 2018-2030 (USD BILLION)
FIGURE 28. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, 2018-2030 (USD BILLION)
FIGURE 29. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, 2018-2030 (USD BILLION)
FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2030 (USD BILLION)
FIGURE 31. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2030 (USD BILLION)
FIGURE 32. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2030 (USD BILLION)
FIGURE 33. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, 2018-2030 (USD BILLION)
FIGURE 34. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, 2018-2030 (USD BILLION)
FIGURE 35. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, 2018-2030 (USD BILLION)
FIGURE 36. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, 2018-2030 (USD BILLION)
FIGURE 37. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, 2018-2030 (USD BILLION)
FIGURE 38. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD BILLION)
FIGURE 39. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD BILLION)
FIGURE 40. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, 2018-2030 (USD BILLION)
FIGURE 41. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, 2018-2030 (USD BILLION)
FIGURE 42. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD BILLION)
FIGURE 43. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, 2018-2030 (USD BILLION)
FIGURE 44. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, 2018-2030 (USD BILLION)
FIGURE 45. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, 2018-2030 (USD BILLION)
FIGURE 46. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD BILLION)
FIGURE 47. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD BILLION)
FIGURE 48. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, 2018-2030 (USD BILLION)
FIGURE 49. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 50. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 51. GLOBAL IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 52. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD BILLION)
FIGURE 53. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD BILLION)
FIGURE 54. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD BILLION)
FIGURE 55. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, 2018-2030 (USD BILLION)
FIGURE 56. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, 2018-2030 (USD BILLION)
FIGURE 57. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD BILLION)
FIGURE 58. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, 2018-2030 (USD BILLION)
FIGURE 59. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD BILLION)
FIGURE 60. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 61. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 62. GLOBAL IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
FIGURE 63. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2030 (USD BILLION)
FIGURE 64. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, 2018-2030 (USD BILLION)
FIGURE 65. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, 2018-2030 (USD BILLION)
FIGURE 66. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 67. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 68. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 69. AMERICAS IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 70. ARGENTINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 71. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 72. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 73. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 74. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 75. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 76. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 77. UNITED STATES IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 78. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 79. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 80. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 81. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 82. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 83. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 84. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 85. INDONESIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 86. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 87. MALAYSIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 88. PHILIPPINES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 89. SINGAPORE IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 90. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 91. TAIWAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 92. THAILAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 93. VIETNAM IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 94. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 95. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 96. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 97. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 98. DENMARK IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 99. EGYPT IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 100. FINLAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 101. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 102. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 103. ISRAEL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 104. ITALY IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 105. NETHERLANDS IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 106. NIGERIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 107. NORWAY IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 108. POLAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 109. QATAR IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 110. RUSSIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 111. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 112. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 113. SPAIN IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 114. SWEDEN IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 115. SWITZERLAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 116. TURKEY IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 117. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 118. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 119. GLOBAL IN-VITRO DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 120. GLOBAL IN-VITRO DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 121. GLOBAL IN-VITRO DIAGNOSTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, 2018-2030 (USD BILLION)
TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD BILLION)
TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD BILLION)
TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD BILLION)
TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD BILLION)
TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2030 (USD BILLION)
TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD BILLION)
TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD BILLION)
TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2018-2030 (USD BILLION)
TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, 2018-2030 (USD BILLION)
TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2018-2030 (USD BILLION)
TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ELECTROLYTE PANEL, BY REGION, 2018-2030 (USD BILLION)
TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, 2018-2030 (USD BILLION)
TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2018-2030 (USD BILLION)
TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2018-2030 (USD BILLION)
TABLE 32. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, 2018-2030 (USD BILLION)
TABLE 33. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY REGION, 2018-2030 (USD BILLION)
TABLE 34. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LIVER PANEL, BY REGION, 2018-2030 (USD BILLION)
TABLE 35. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, 2018-2030 (USD BILLION)
TABLE 36. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY REGION, 2018-2030 (USD BILLION)
TABLE 37. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RENAL PROFILE, BY REGION, 2018-2030 (USD BILLION)
TABLE 38. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, 2018-2030 (USD BILLION)
TABLE 39. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 40. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIALTY CHEMICAL TESTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 41. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, 2018-2030 (USD BILLION)
TABLE 42. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY REGION, 2018-2030 (USD BILLION)
TABLE 43. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY THYROID FUNCTION PANEL, BY REGION, 2018-2030 (USD BILLION)
TABLE 44. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, 2018-2030 (USD BILLION)
TABLE 45. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY REGION, 2018-2030 (USD BILLION)
TABLE 46. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COAGULATION & HEMOSTASIS, BY REGION, 2018-2030 (USD BILLION)
TABLE 47. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2030 (USD BILLION)
TABLE 48. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 49. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 50. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2030 (USD BILLION)
TABLE 51. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2030 (USD BILLION)
TABLE 52. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2030 (USD BILLION)
TABLE 53. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, 2018-2030 (USD BILLION)
TABLE 54. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD BILLION)
TABLE 55. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD BILLION)
TABLE 56. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, 2018-2030 (USD BILLION)
TABLE 57. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 58. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 59. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, 2018-2030 (USD BILLION)
TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 61. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 62. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, 2018-2030 (USD BILLION)
TABLE 63. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 64. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, 2018-2030 (USD BILLION)
TABLE 66. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 67. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ENZYME-LINKED IMMUNOSPOT ASSAYS, BY REGION, 2018-2030 (USD BILLION)
TABLE 68. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD BILLION)
TABLE 69. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD BILLION)
TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD BILLION)
TABLE 71. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, 2018-2030 (USD BILLION)
TABLE 72. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2030 (USD BILLION)
TABLE 73. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2030 (USD BILLION)
TABLE 74. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, 2018-2030 (USD BILLION)
TABLE 75. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2030 (USD BILLION)
TABLE 76. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2030 (USD BILLION)
TABLE 77. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, 2018-2030 (USD BILLION)
TABLE 78. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 79. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 80. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD BILLION)
TABLE 81. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 82. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 83. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, 2018-2030 (USD BILLION)
TABLE 84. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD BILLION)
TABLE 85. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD BILLION)
TABLE 86. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, 2018-2030 (USD BILLION)
TABLE 87. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY REGION, 2018-2030 (USD BILLION)
TABLE 88. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HYBRIDIZATION, BY REGION, 2018-2030 (USD BILLION)
TABLE 89. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 90. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 91. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 92. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD BILLION)
TABLE 93. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD BILLION)
TABLE 94. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD BILLION)
TABLE 95. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD BILLION)
TABLE 96. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD BILLION)
TABLE 97. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD BILLION)
TABLE 98. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, 2018-2030 (USD BILLION)
TABLE 99. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2030 (USD BILLION)
TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2030 (USD BILLION)
TABLE 101. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 102. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2030 (USD BILLION)
TABLE 103. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD BILLION)
TABLE 104. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD BILLION)
TABLE 105. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD BILLION)
TABLE 106. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 107. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 108. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2030 (USD BILLION)
TABLE 109. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD BILLION)
TABLE 110. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD BILLION)
TABLE 111. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, 2018-2030 (USD BILLION)
TABLE 112. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD BILLION)
TABLE 113. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD BILLION)
TABLE 114. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, 2018-2030 (USD BILLION)
TABLE 115. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2030 (USD BILLION)
TABLE 116. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2030 (USD BILLION)
TABLE 117. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD BILLION)
TABLE 118. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD BILLION)
TABLE 119. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD BILLION)
TABLE 120. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, 2018-2030 (USD BILLION)
TABLE 121. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 122. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 123. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD BILLION)
TABLE 124. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 125. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 126. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 127. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2030 (USD BILLION)
TABLE 128. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD BILLION)
TABLE 129. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD BILLION)
TABLE 130. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, 2018-2030 (USD BILLION)
TABLE 131. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 132. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 133. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, 2018-2030 (USD BILLION)
TABLE 134. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY REGION, 2018-2030 (USD BILLION)
TABLE 135. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT SELF-TESTING, BY REGION, 2018-2030 (USD BILLION)
TABLE 136. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 137. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 138. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 139. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 140. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 141. AMERICAS IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 142. ARGENTINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 143. ARGENTINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 144. ARGENTINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 145. ARGENTINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 146. ARGENTINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 147. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 148. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 149. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 150. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 151. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 152. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 153. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 154. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 155. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 156. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 157. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 158. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 159. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 160. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 161. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 162. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 163. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 164. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 165. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 166. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 167. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 168. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 169. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 170. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 171. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 172. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 173. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 174. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 175. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 176. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 177. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 178. AUSTRALIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 179. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 180. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 181. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 182. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 183. CHINA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 184. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 185. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 186. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 187. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 188. INDIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 189. INDONESIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 190. INDONESIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 191. INDONESIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 192. INDONESIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 193. INDONESIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 194. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 195. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 196. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 197. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 198. JAPAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 199. MALAYSIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 200. MALAYSIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 201. MALAYSIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 202. MALAYSIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 203. MALAYSIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 204. PHILIPPINES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 205. PHILIPPINES IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 206. PHILIPPINES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 207. PHILIPPINES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 208. PHILIPPINES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 209. SINGAPORE IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 210. SINGAPORE IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 211. SINGAPORE IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 212. SINGAPORE IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 213. SINGAPORE IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 214. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 215. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 216. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 217. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 218. SOUTH KOREA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 219. TAIWAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 220. TAIWAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 221. TAIWAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 222. TAIWAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 223. TAIWAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 224. THAILAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 225. THAILAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 226. THAILAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 227. THAILAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 228. THAILAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 229. VIETNAM IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 230. VIETNAM IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 231. VIETNAM IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 232. VIETNAM IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 233. VIETNAM IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 240. DENMARK IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 241. DENMARK IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 242. DENMARK IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 243. DENMARK IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 244. DENMARK IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 245. EGYPT IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 246. EGYPT IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 247. EGYPT IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 248. EGYPT IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 249. EGYPT IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 250. FINLAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 251. FINLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 252. FINLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 253. FINLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 254. FINLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 255. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 256. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 257. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 258. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 259. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 260. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 261. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 262. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 263. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 264. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 265. ISRAEL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 266. ISRAEL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 267. ISRAEL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 268. ISRAEL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 269. ISRAEL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 270. ITALY IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 271. ITALY IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 272. ITALY IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 273. ITALY IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 274. ITALY IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 275. NETHERLANDS IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 276. NETHERLANDS IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 277. NETHERLANDS IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 278. NETHERLANDS IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 279. NETHERLANDS IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 280. NIGERIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 281. NIGERIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 282. NIGERIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 283. NIGERIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 284. NIGERIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 285. NORWAY IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 286. NORWAY IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 287. NORWAY IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 288. NORWAY IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 289. NORWAY IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 290. POLAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 291. POLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 292. POLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 293. POLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 294. POLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 295. QATAR IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 296. QATAR IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 297. QATAR IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 298. QATAR IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 299. QATAR IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 300. RUSSIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 301. RUSSIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 302. RUSSIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 303. RUSSIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 304. RUSSIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 305. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 306. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 307. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 308. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 309. SAUDI ARABIA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 310. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 311. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 312. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 313. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 314. SOUTH AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 315. SPAIN IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 316. SPAIN IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 317. SPAIN IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 318. SPAIN IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 319. SPAIN IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 320. SWEDEN IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 321. SWEDEN IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 322. SWEDEN IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 323. SWEDEN IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 324. SWEDEN IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 325. SWITZERLAND IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 326. SWITZERLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 327. SWITZERLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 328. SWITZERLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 329. SWITZERLAND IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 330. TURKEY IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 331. TURKEY IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 332. TURKEY IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 333. TURKEY IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 334. TURKEY IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 335. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 336. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 337. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 338. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 339. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 340. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 341. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 342. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
TABLE 343. UNITED KINGDOM IN-VIT

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Arkray Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Biomérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Grifols SA
  • Ortho-Clinical Diagnostics, Inc.
  • Qiagen GmbH
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...